Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.

Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization. Oncologist. 2016 06; 21(6):762-70.

View in: PubMed

subject areas

Adult
Aged
Carcinoma, Non-Small-Cell Lung
Female
Gene Expression Profiling
Gene Rearrangement
Genomics
Humans
In Situ Hybridization, Fluorescence
Lung Neoplasms
Male
Protein Kinase Inhibitors
Pyrazoles
Pyridines
Receptor Protein-Tyrosine Kinases

authors with profiles

Thomas Hensing
Ravi Salgia